Leap Therapeutics, Inc. (LPTX)
NASDAQ: LPTX · IEX Real-Time Price · USD
2.080
+0.010 (0.48%)
Jul 22, 2024, 9:56 AM EDT - Market open
Leap Therapeutics Employees
Leap Therapeutics had 54 employees as of December 31, 2023. The number of employees increased by 10 or 22.73% compared to the previous year.
Employees
54
Change (1Y)
10
Growth (1Y)
22.73%
Revenue / Employee
n/a
Profits / Employee
-$988,352
Market Cap
81.34M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Marinus Pharmaceuticals | 166 |
Affimed | 76 |
Boundless Bio | 72 |
PMV Pharmaceuticals | 63 |
Milestone Pharmaceuticals | 47 |
Ikena Oncology | 43 |
Forian | 37 |
Oncolytics Biotech | 29 |
LPTX News
- 2 months ago - Leap Therapeutics Reports First Quarter 2024 Financial Results - PRNewsWire
- 3 months ago - Leap Therapeutics Announces $40 Million Private Placement - PRNewsWire
- 4 months ago - Leap Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results - PRNewsWire
- 6 months ago - Leap Therapeutics to Present New Clinical Data from Part A of DeFianCe Study at the 2024 ASCO Gastrointestinal Cancers Symposium - PRNewsWire
- 7 months ago - Leap Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 7 months ago - Leap Therapeutics Announces Completion of Enrollment in Randomized Controlled Part C of the DisTinGuish Study of DKN-01 for the Treatment of Gastric Cancer Patients - PRNewsWire
- 7 months ago - Leap Therapeutics to Present New Data from Part A of the DeFianCe Study of DKN-01 Plus Bevacizumab and Chemotherapy in Colorectal Cancer Patients at the 2024 ASCO Gastrointestinal Cancers Symposium - PRNewsWire
- 8 months ago - Leap Therapeutics to Participate at Piper Sandler 35th Annual Healthcare Conference - PRNewsWire